» Authors » Akio Yokoseki

Akio Yokoseki

Explore the profile of Akio Yokoseki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 49
Citations 877
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishihara T, Koyama A, Atsuta N, Tada M, Toyoda S, Kashiwagi K, et al.
BMC Med Genomics . 2024 Nov; 17(1):263. PMID: 39506867
Background: The copy number status (CNS) of the survival motor neuron (SMN) gene may influence the risk and prognosis of amyotrophic lateral sclerosis (ALS) and lower motor neuron diseases (LMND)...
2.
Lyu H, Sugita N, Komatsu S, Wakasugi M, Yokoseki A, Yoshihara A, et al.
Heliyon . 2024 Jul; 10(12):e32512. PMID: 38952382
Objective: Uncoupling protein 2 (UCP2) is an ion/anion transporter in the mitochondrial inner membrane that plays a crucial role in immune response, regulation of oxidative stress, and cellular metabolism. UCP2...
3.
Ueda T, Takeuchi T, Fujikake N, Suzuki M, Minakawa E, Ueyama M, et al.
Acta Neuropathol Commun . 2024 Feb; 12(1):20. PMID: 38311779
The abnormal aggregation of TDP-43 into cytoplasmic inclusions in affected neurons is a major pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Although TDP-43 is aberrantly accumulated...
4.
Wakasugi M, Yokoseki A, Wada M, Yoshino T, Momotsu T, Sato K, et al.
Intern Med . 2023 Oct; 63(9):1207-1216. PMID: 37779071
Objective Cataract and chronic kidney disease (CKD) occur with increasing frequency with age and share common risk factors including smoking, diabetes, and hypertension. We evaluated the risk of incident cataract...
5.
Wakasugi M, Yokoseki A, Wada M, Momotsu T, Sato K, Kawashima H, et al.
J Ren Nutr . 2023 Feb; 33(4):566-574. PMID: 36791982
Objective: Patients with advanced chronic kidney disease (CKD) are generally discouraged from consuming high amounts of vegetables and fruits given the potential risk of hyperkalemia. In the general population, however,...
6.
Wakasugi M, Yokoseki A, Wada M, Sanpei K, Momotsu T, Sato K, et al.
Nephrology (Carlton) . 2022 Apr; 27(7):577-587. PMID: 35488413
Aim: This prospective cohort study aimed to (i) examine stroke incidence and stroke subtypes by chronic kidney disease (CKD) stage, (ii) examine whether CKD patients with or without proteinuria have...
7.
Wakasugi M, Yokoseki A, Wada M, Momotsu T, Sato K, Kawashima H, et al.
J Bone Miner Metab . 2022 Feb; 40(3):537-538. PMID: 35184207
No abstract available.
8.
Wakasugi M, Yokoseki A, Wada M, Momotsu T, Sato K, Kawashima H, et al.
J Bone Miner Metab . 2021 Nov; 40(1):157-166. PMID: 34729651
Introduction: Polypharmacy is associated with an increased risk of fracture in aging populations, but no study has accounted for the impact of kidney function on this association. This study aimed...
9.
Koike Y, Sugai A, Hara N, Ito J, Yokoseki A, Ishihara T, et al.
Commun Biol . 2021 Sep; 4(1):1107. PMID: 34548609
In amyotrophic lateral sclerosis (ALS), TAR DNA-binding protein 43 (TDP-43), which is encoded by TARDBP, forms aggregates in the motor cortex. This aggregate formation may be triggered by an increase...
10.
Sainouchi M, Hatano Y, Tada M, Ishihara T, Ando S, Kato T, et al.
Acta Neuropathol Commun . 2021 Jun; 9(1):115. PMID: 34183068
No abstract available.